Distribution of Cortical Benzodiazepine Receptor Binding in Right-Handed Healthy Humans: A Voxel-Based Statistical Analysis of Iodine 123 Iomazenil SPECT with Partial Volume Correction

References

1. 1.↵
   1. Sybirska E,
   2. al-Tikriti M,
   3. Zoghbi SS,
   4. et al

   . SPECT imaging of the benzodiazepine receptor: autoradiographic comparison of receptor density and radioligand distribution. Synapse 1992;12:119–28

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Kato H,
   2. Shimosegawa E,
   3. Oku N,
   4. et al

   . MRI-based correction for partial-volume effect improves detectability of intractable epileptogenic foci on 123I-iomazenil brain SPECT images. J Nucl Med 2008;49:383–89

   Abstract/FREE Full Text
3. 3.↵
   1. Good CD,
   2. Johnsrude IS,
   3. Ashburner J,
   4. et al

   . A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001;14:21–36

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Oldfield RC

   . The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97–113

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Kiernan RJ,
   2. Mueller J,
   3. Langston JW,
   4. et al

   . The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med 1987;107:481–85

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Onishi Y,
   2. Yonekura Y,
   3. Mukai T,
   4. et al

   . Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans. J Nucl Med 1995;36:1201–10

   Abstract/FREE Full Text
7. 7.↵
   1. Kimura K,
   2. Hashikawa K,
   3. Etani H,
   4. et al

   . A new apparatus for brain imaging: four-head rotating gamma camera single-photon emission computed tomograph. J Nucl Med 1990;31:603–09

   Abstract/FREE Full Text
8. 8.↵
   1. Chang LT

   . A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638–43

   CrossRefWeb of Science
9. 9.↵
   1. Onishi Y,
   2. Yonekura Y,
   3. Nishizawa S,
   4. et al

   . Noninvasive quantification of iodine-123-iomazenil SPECT. J Nucl Med 1996;37:374–78

   Abstract/FREE Full Text
10. 10.↵
    1. Mintun MA,
    2. Raichle ME,
    3. Kilbourn MR,
    4. et al

    . A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984;15:217–27

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Ashburner J,
    2. Friston KJ

    . Unified segmentation. Neuroimage 2005;26:839–51

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Ashburner J,
    2. Friston KJ

    . Voxel-based morphometry: the methods. Neuroimage 2000;11:805–21

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Matsuda H,
    2. Ohnishi T,
    3. Asada T,
    4. et al

    . Correction for partial-volume effects on brain perfusion SPECT in healthy men. J Nucl Med 2003;44:1243–52

    Abstract/FREE Full Text
14. 14.↵
    1. Ibanez V,
    2. Pietrini P,
    3. Alexander GE,
    4. et al

    . Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998;50:1585–93

    Abstract/FREE Full Text
15. 15.↵
    1. Jenkinson M,
    2. Smith S

    . A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143–56

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Tzourio-Mazoyer N,
    2. Landeau B,
    3. Papathanassiou D,
    4. et al

    . Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Friston KJ,
    2. Holmes AP,
    3. Worsley KJ,
    4. et al

    . Statistic parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189–210

    CrossRef
18. 18.↵
    1. Muller-Gartner HW,
    2. Links JM,
    3. Prince JL,
    4. et al

    . Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab 1992;12:571–83

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Ruano D,
    2. Machado A,
    3. Vitorica J

    . Absence of modifications of the pharmacological properties of the GABAA receptor complex during aging, as assessed in 3- and 24-month-old rat cerebral cortex. Eur J Pharmacol 1993;246:81–87

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Ruano D,
    2. Araujo F,
    3. Bentareha R,
    4. et al

    . Age-related modifications on the GABAA receptor binding properties from Wistar rat prefrontal cortex. Brain Res 1996;738:103–08

    CrossRefPubMed
21. 21.↵
    1. Suhara T,
    2. Inoue O,
    3. Kobayashi K,
    4. et al

    . No age-related changes in human benzodiazepine receptor binding measured by PET with [11C]Ro 15–4513. Neurosci Lett 1993;159:207–10

    CrossRefPubMed
22. 22.↵
    1. Zezula J,
    2. Cortes R,
    3. Probst A,
    4. et al

    . Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience 1988;25:771–95

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Hoekzema E,
    2. Rojas S,
    3. Herance R,
    4. et al

    . In vivo molecular imaging of the GABA/benzodiazepine receptor complex in the aged rat brain. Neurobiol Aging 2012;33:1457–65

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Driscoll I,
    2. Howard SR,
    3. Stone JC,
    4. et al

    . The aging hippocampus: a multi-level analysis in the rat. Neuroscience 2006;139:1173–85

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Steinmetz H,
    2. Volkmann J,
    3. Jancke L,
    4. et al

    . Anatomical left-right asymmetry of language-related temporal cortex is different in left- and right-handers. Ann Neurol 1991;29:315–19

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Herve PY,
    2. Crivello F,
    3. Perchey G,
    4. et al

    . Handedness and cerebral anatomical asymmetries in young adult males. Neuroimage 2006;29:1066–79

    CrossRefPubMedWeb of Science